New data reveals optimal timing for percutaneous coronary intervention in TAVR patients

FHS
May 4, 2024
3:40 am

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery disease (CAD).

Uninsured rate hits ‘record low’ — right before millions start losing Medicaid coverage

Roughly 7.7% of Americans didn’t have any health insurance as of this past March — a “record low” uninsured rate, according to the latest health

August 3, 2023

NIHR reports positive signs of recovery for the life sciences industry – Lifescience Industry News

Commercial research is showing clear signs of recovery since the pandemic according to the latest annual statistics reported by the NIHR Clinical Research Network (CRN).

July 13, 2023

Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.